Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWilmington Regulatory News (WIL)

Share Price Information for Wilmington (WIL)

Share Price is delayed by 15 minutes
Get Live Data
276.00    11.00 (4.15%)
Bid:
268.00
Ask:
272.00
Spread: 4.00 (1.493%)
Market Cap: £247.17m
WIL Live PriceLast checked at - London Stock Exchange

Intraday Wilmington Share Chart

Acquisition

19 Jan 2016 07:00

RNS Number : 2460M
Wilmington PLC
19 January 2016
 

 

19 January 2016

Wilmington plc

 

Acquisition of JMH Publishing Limited trading as "Wellards"

 

· Acquisition adds online education capability for the Insight knowledge area 

 

· Wellards extensive NHS knowledge base strengthens Wilmington's Healthcare offering

 

· High quality revenue streams - 70% from subscription products with over 90% renewal rates

 

Wilmington plc ("Wilmington" or "the Group"), the knowledge leader in Risk & Compliance, Finance, Legal, and Insight, announces the acquisition of JMH Publishing Ltd ("Wellards" or "the business"), a leading UK provider of specialist and accredited online education for the healthcare industry and owner of the respected trading brand "Wellards".

 

As part of Wilmington, Wellards will become the principal education and training platform for the Insight division and will benefit from Wilmington's enhanced healthcare market access, both in the UK and in mainland Europe.

 

Terms of the deal

 

Wilmington is acquiring Wellards for an initial consideration of £4.2m payable in cash. Wellards is being acquired with £1.3m of cash in its balance sheet. A final payment of up to £0.9m in March 2016 will be made once the final net current asset position has been agreed.

 

The consideration will be financed out of the Group's existing £65.0m multicurrency debt facility and is expected to be earnings enhancing in the first full year of ownership.

 

Background to Wellards

 

Wellards, established in 1990 is based in Kent, England and is managed by its founder John Heath, CEO who will remain with the business for a transitional period of one year. Wellards core online modules deliver the industry standard for effective and comprehensive NHS training and are an indispensable resource to enable understanding of the NHS and how it functions.

 

Wellards runs over 70 online courses and has more than 25,000 registered users. Subjects covered include critical areas for pharma industry representatives such as market access and financial flows, clinical modules of key therapy areas such as cancer, diabetes and cardiovascular health, ABPI code and compliance. Over 70% of its revenue is generated by its online training portal, Wellards Academy, which services the needs of UK pharmaceutical and Medtech commercial staff.

 

In the twelve month period ended 31 October 20151, revenue per the unaudited management accounts was £2.0m, an increase of 12 percent on the same period in 2014 and the adjusted profit before interest, amortisation and taxation was £0.6m1. Gross assets were 2.0m1. Wellards will provide Wilmington with an additional attractive recurring revenue stream as over 70% of its revenue is subscription based with over 90% renewal rates.

 

Acquisition rationale

 

The acquisition of Wellards is consistent with Wilmington's strategy of acquiring complementary businesses with high repeat revenues and strong, cash generative income streams in the Group's key markets. The addition of Wellards provides Wilmington with education capability for its Insight division completing the strategic objective of having information, networking and education offerings across all of Wilmington's four knowledge areas.

 

1 unaudited.

 

Commenting on the acquisition, Pedro Ros, Chief Executive Officer of Wilmington, said:

 

"I am delighted to welcome Wellards to Wilmington; its addition completes one of our strategic objectives of having information, education and networking capabilities for each of our knowledge areas. I am particularly excited by the scalability of the online products both in the broader healthcare industry and internationally where we can utilise our existing market access in particular to the French and German healthcare markets."

 

John Heath, founder and CEO of Wellards commented: 

 

"I'm delighted that Wellards is now part of Wilmington. For many years we have worked closely with Binleys; a business within Wilmington's Insight division, providing customers with the knowledge and insight needed to interpret the practical value of the Binleys resource and this acquisition is a very natural extension of our partnership.

 

I'm looking forward to developing new services which will enhance the product portfolio of both companies"

 

For further information, please contact:

Wilmington plc

Pedro Ros, Chief Executive Officer

Tony Foye, Chief Financial Officer

020 7422 6800

FTI Consulting

Charles Palmer

Emma Appleton

020 3727 1000

 

Notes to Editors

 

Wilmington plc is the recognised knowledge leader and partner of choice for information, education and networking in Risk & Compliance, Finance and Legal as well as the Insight leader in a number of chosen industries. Capitalised at approximately £225 million, Wilmington floated on the London Stock Exchange in 1995.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQFVLLFQFFBBBF
Date   Source Headline
4th Aug 200611:01 amRNSMerger Update
2nd Aug 200610:52 amRNSAdjournment of EGM
1st Aug 20065:20 pmRNSAdjournment of EGM
26th Jul 20065:39 pmRNSResponse to Possible Offer
14th Jul 20067:00 amRNSRule 8.4 Disclosure
12th Jul 200611:11 amRNSDisclosure Rule 8.4
10th Jul 20061:32 pmRNSMerger Update
10th Jul 20061:06 pmRNSRule 8.3-Wilmington Group Plc
7th Jul 20064:41 pmRNSDisclosure under Rule 8.4
29th Jun 20061:16 pmRNSRule 8.4 Disclosure
26th Jun 20067:00 amRNSMerger
15th May 20067:01 amRNSAcquisition
16th Mar 20067:03 amRNSInterim Results
15th Feb 200610:33 amRNSNotice of Results
9th Feb 20067:00 amRNSAcquisition
13th Jan 20066:01 pmRNSHolding(s) in Company
9th Jan 20066:15 pmRNSHolding(s) in Company
8th Dec 20057:00 amRNSTrading Statement
21st Nov 20055:17 pmRNSHolding(s) in Company
21st Nov 20055:17 pmRNSHolding(s) in Company
16th Nov 20053:01 pmRNSDirector/PDMR Shareholding
11th Nov 20053:39 pmRNSHolding(s) in Company
9th Nov 20053:32 pmRNSAGM Statement
9th Nov 20057:01 amRNSIFRS Statement
27th Oct 20055:10 pmRNSDirector/PDMR Shareholding
20th Oct 20057:04 amRNSAcquisition
19th Oct 20059:22 amRNSAnnual Information Update
6th Oct 200512:12 pmRNSAnnual Report and Accounts
29th Sep 200511:28 amRNSHolding(s) in Company
22nd Sep 20059:22 amRNSDirector/PDMR Shareholding
15th Sep 20057:03 amRNSFinal Results
13th Sep 20051:25 pmRNSDisposal
26th Aug 200511:52 amRNSNotice of Results
14th Jul 20057:00 amRNSPre-Close Period Statement
16th Jun 20057:00 amRNSBoard Changes
19th May 20057:00 amRNSAcquisition
7th Apr 20057:00 amRNSDirectorate Change
24th Feb 20057:01 amRNSInterim Results
22nd Feb 20053:38 pmRNSAdditional Listing
25th Jan 20057:00 amRNSNotice of Results
19th Jan 20057:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.